A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience

Breast J. 2006 Nov-Dec;12(6):578-84. doi: 10.1111/j.1524-4741.2006.00353.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents, Hormonal / adverse effects*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Endometrial Neoplasms / chemically induced*
  • Endometrial Neoplasms / mortality
  • Endometrial Neoplasms / pathology
  • Female
  • Humans
  • Middle Aged
  • Postmenopause
  • Survival Rate
  • Tamoxifen / adverse effects*
  • Tamoxifen / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Tamoxifen